Table of Contents Author Guidelines Submit a Manuscript
Journal of Chemistry
Volume 2015, Article ID 376527, 7 pages
http://dx.doi.org/10.1155/2015/376527
Research Article

Design, Synthesis, and In Vitro Antiplatelet Aggregation Activities of Ferulic Acid Derivatives

Jiangsu Collaborative Innovation Center of Chinese Medicine Resources Industrialization, Jiangsu Key Laboratory for High Technology Research of TCM Formulae, and National and Local Collaborative Engineering Center of Chinese Medicine Resources, Nanjing University of Chinese Medicine, Nanjing 210023, China

Received 31 January 2015; Revised 15 March 2015; Accepted 15 March 2015

Academic Editor: Maria N. D. S. Cordeiro

Copyright © 2015 Peng-Xuan Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. J. Marder, M. H. Rosove, and D. M. Minning, “Foundation and sites of action of antithrombotic agents,” Best Practice and Research: Clinical Haematology, vol. 17, no. 1, pp. 3–22, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. F. Philippe, G. Drobinski, C. Bucherer et al., “Effects of ultrasound energy on thrombi in vitro,” Catheterization and Cardiovascular Diagnosis, vol. 28, no. 2, pp. 173–178, 1993. View at Publisher · View at Google Scholar · View at Scopus
  3. S. B. Olsson, B. Johansson, A. M. Nilsson, C. Olsson, and A. Roijer, “Enhancement of thrombolysis by ultrasound,” Ultrasound in Medicine and Biology, vol. 20, no. 4, pp. 375–382, 1994. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Abdel-Razeq, M. Qari, J. Kristensen et al., “Guidelines for diagnosis and treatment of deep venous thrombosis and pulmonary embolism,” Methods in Molecular Medicine, vol. 93, pp. 267–292, 2004. View at Google Scholar · View at Scopus
  5. A. D. Lopez, C. D. Mathers, M. Ezzati, D. T. Jamison, and C. J. Murray, “Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data,” The Lancet, vol. 367, no. 9524, pp. 1747–1757, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Cruz-Gonzalez, J. Martín Moreiras, and E. García, “Thrombus formation after left atrial appendage exclusion using an amplatzer cardiac plug device,” Catheterization and Cardiovascular Interventions, vol. 78, no. 6, pp. 970–973, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. M. H. Meissner, P. Gloviczki, A. J. Comerota et al., “Early thrombus removal strategies for acute deep venous thrombosis: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum,” Journal of Vascular Surgery, vol. 55, no. 5, pp. 1449–1462, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. Y.-D. Chen, Y.-L. Lu, Z.-N. Jin, F. Yuan, and S.-Z. Lü, “A prospective randomized antiplatelet trial of cilostazol versus clopidogrel in patients with bare metal stent,” Chinese Medical Journal, vol. 119, no. 5, pp. 360–366, 2006. View at Google Scholar · View at Scopus
  9. S. R. Steinhubl, P. B. Berger, J. T. Mann III et al., “Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial,” Journal of the American Medical Association, vol. 288, no. 19, pp. 2411–2420, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. K. M. Youssef, M. A. Al-Omar, H. I. El-Subbagh et al., “Synthesis, antiplatelet aggregation activity, and molecular modeling study of novel substituted-piperazine analogues,” Medicinal Chemistry Research, vol. 20, no. 7, pp. 898–911, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. X. F. Wang, N. H. Chen, and W. Wang, “Advance in the mechanism of anti-platelet aggregation drugs,” Chinese Journal of Rehabilitation Theory and Practice, vol. 16, p. 10, 2010. View at Google Scholar
  12. E. R. Bates and W. C. Lau, “Controversies in antiplatelet therapy for patients with cardiovascular disease,” Circulation, vol. 111, no. 17, pp. e267–e271, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Niv, A. Battler, G. Abuksis, E. Gal, B. Sapoznikov, and A. Vilkin, “Endoscopy in asymptomatic minidose aspirin consumers,” Digestive Diseases and Sciences, vol. 50, no. 1, pp. 78–80, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Yamamoto, K. Shiraki, Y. Saitou et al., “Ticlopidine induced acute cholestatic hepatitis complicated with pure red cell aplasia,” Journal of Clinical Gastroenterology, vol. 38, article 84, 2004. View at Google Scholar · View at Scopus
  15. C. L. Campbell, S. Smyth, G. Montalescot, and S. R. Steinhubl, “Aspirin dose for the prevention of cardiovascular disease: a systematic review,” The Journal of the American Medical Association, vol. 297, no. 18, pp. 2018–2024, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Nithyanandam, M. Joseph, and T. Mathew, “Clinical profile of cerebral venous thrombosis and the role of imaging in its diagnosis in patients with presumed idiopathic intracranial hypertension,” Indian Journal of Ophthalmology, vol. 59, no. 2, pp. 169–170, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Battaglia, E. Stragliotto, and F. Heiman, “Indobufen in the secondary prevention of cerebral ischemic attack (TIA): a prospective, randomized, controlled study,” Thrombosis and Haemostasis, vol. 69, pp. 1349–1358, 1993. View at Google Scholar
  18. B. Girolami, E. Bernardi, M. H. Prins et al., “Antithrombotic drugs in the primary medical management of intermittent claudication: a meta-analysis,” Thrombosis and Haemostasis, vol. 81, no. 5, pp. 715–722, 1999. View at Google Scholar
  19. G. Fornaro, P. Rossi, P. G. Mantica et al., “Indobufen in the prevention of thromboembolic complications in patients with heart disease: a randomized, placebo-controlled, double-blind study,” Circulation, vol. 87, no. 1, pp. 162–164, 1993. View at Publisher · View at Google Scholar · View at Scopus
  20. S. M. Rajah, U. Nair, M. Rees et al., “Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting,” The Journal of Thoracic and Cardiovascular Surgery, vol. 107, no. 4, pp. 1146–1153, 1994. View at Google Scholar · View at Scopus
  21. E. Jura-Szołtys and J. Chudek, “Epistaxis as the reason for premature discontinuation of clopidogrel after percutaneous coronary angioplasty with stent implantation,” Kardiologia Polska, vol. 69, no. 8, pp. 817–823, 2011. View at Google Scholar · View at Scopus
  22. P. Libby, “Mechanisms of acute coronary syndromes and their implications for therapy,” The New England Journal of Medicine, vol. 368, no. 21, pp. 2004–2013, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. D. R. Guerra and J. E. Tcheng, “Prasugrel: clinical development and therapeutic application,” Advances in Therapy, vol. 26, no. 11, pp. 999–1011, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. S. C. Fry, “Phenolic components of the primary cell wall. Feruloylated disaccharides of D-galactose and L-arabinose from spinach polysaccharide,” Biochemical Journal, vol. 203, no. 2, pp. 493–504, 1982. View at Google Scholar · View at Scopus
  25. M. S. Izydorczyk and C. G. Biliaderis, “Cereal arabinoxylans: advances in structure and physicochemical properties,” Carbohydrate Polymers, vol. 28, no. 1, pp. 33–48, 1995. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Alonso García, B. Cancho Grande, and J. Simal Gándara, “Development of a rapid method based on solid-phase extraction and liquid chromatography with ultraviolet absorbance detection for the determination of polyphenols in alcohol-free beers,” Journal of Chromatography A, vol. 1054, no. 1-2, pp. 175–180, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Kivilompolo and T. Hyötyläinen, “Comprehensive two-dimensional liquid chromatography in analysis of Lamiaceae herbs: characterisation and quantification of antioxidant phenolic acids,” Journal of Chromatography A, vol. 1145, no. 1-2, pp. 155–164, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Colaric, R. Veberic, A. Solar, M. Hudina, and F. Stampar, “Phenolic acids, syringaldehyde, and juglone in fruits of different cultivars of Juglans regia L.,” Journal of Agricultural and Food Chemistry, vol. 53, no. 16, pp. 6390–6396, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Barone, V. Calabrese, and C. Mancuso, “Ferulic acid and its therapeutic potential as a hormetin for age-related diseases,” Biogerontology, vol. 10, no. 2, pp. 97–108, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. W. Russell and G. Duthie, “Plant secondary metabolites and gut health: the case for phenolic acids,” The Proceedings of the Nutrition Society, vol. 70, no. 3, pp. 389–396, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Kayahara, Z. Miao, and G. Fujiwara, “Synthesis and biological activities of ferulic acid derivatives,” Anticancer Research, vol. 19, no. 5 A, pp. 3763–3768, 1999. View at Google Scholar · View at Scopus
  32. W. R. Russell, A. Labat, L. Scobbie, and S. H. Duncan, “Availability of blueberry phenolics for microbial metabolism in the colon and the potential inflammatory implications,” Molecular Nutrition and Food Research, vol. 51, no. 6, pp. 726–731, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. P. Tang, J. A. Duan, X. S. Fan, E. X. Shang, S. L. Su, and A. W. Ding, “Effects of aromatic acids on stimulating blood circulation and removing blood stasis,” World Science and Technology, vol. 10, no. 4, pp. 38–42, 2008. View at Google Scholar
  34. D. L. A. Rakotondramanana, M. Delomenède, M. Baltas et al., “Synthesis of ferulic ester dimers, functionalisation and biological evaluation as potential antiatherogenic and antiplasmodial agents,” Bioorganic & Medicinal Chemistry, vol. 15, no. 18, pp. 6018–6026, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. Z.-H. Shi, N.-G. Li, Q.-P. Shi et al., “Design, synthesis and biological evaluation of caffeic acid amides as selective MMP-2 and MMP-9 inhibitors,” Drug Development Research, vol. 73, no. 6, pp. 343–351, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Tang, G. Jiang, and S. Wang, “Studies on synthesis and pharmacological activity of ferulic acid salts,” Chinese Pharmaceutical Journal, vol. 34, no. 10, pp. 697–699, 1999. View at Google Scholar · View at Scopus
  37. X. J. Liu, X. X. Shi, Y. L. Zhong, N. Liu, and K. Liu, “Design, synthesis and in vitro activities on anti-platelet aggregation of 4-methoxybenzene-1,3-isophthalamides,” Bioorganic and Medicinal Chemistry Letters, vol. 22, no. 21, pp. 6591–6595, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. G. V. R. Born, “Aggregation of blood platelets by adenosine diphosphate and its reversal,” Nature, vol. 194, no. 4832, pp. 927–929, 1962. View at Publisher · View at Google Scholar · View at Scopus
  39. L. M. Ostertag, N. O'Kennedy, G. W. Horgan, P. A. Kroon, G. G. Duthie, and B. de Roos, “In vitro anti-platelet effects of simple plant-derived phenolic compounds are only found at high, non-physiological concentrations,” Molecular Nutrition and Food Research, vol. 55, no. 11, pp. 1624–1636, 2011. View at Publisher · View at Google Scholar · View at Scopus